Fundraising Fox

Cassidy Blundell

Investor

Partner at Mission Biocapital

Cambridge, Massachusetts

Writes $500K checks · typically $1.5M

About

Cassidy Blundell, PhD (UPenn HHMI Interfaces), is a builder-investor whose placental organ-on-chip research informs her interim operational roles at very early-stage biotech startups and represents a fund on multiple boards.

LinkedIn ↗

Invests in

AgTechBiotechFoodTechHealthtechMedical DevicesNew Materials

Experience

  1. Mission BioCapitalPartnercurrent2024 — presentCambridge, Massachusetts, United States
  2. Mission BioCapitalPrincipal2021 — 2024
  3. Mission BioCapitalAssociate2019 — 2021
  4. Mission BioCapitalAnalyst2018 — 2019
  5. University of PennsylvaniaBioengineering PhD Student2012 — 2018Philadelphia, Pennsylvania, United States
  6. Flagship PioneeringVentureLabs Fellow2017Cambridge, Massachusetts, United States
  7. Firefly BioworksBioassay Scientist2011

Education

  1. University of PennsylvaniaDoctor of Philosophy (PhD), Bioengineering
  2. Boston UniversityB.S., Biomedical Engineering

Skills & more

Immunofluorescence3Biomedical Engineering7Cell Culture2Microfluidics1Research4SolidWorks1Matlab1LabVIEWPolymerase Chain Reaction (PCR)MicroscopyMicrosoft Excel1Data Analysis1
+1 moreMolecular Biology

From Cassidy's professional profile.

Same school

Also attended University of Pennsylvania606

Dasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC PartnersAkshat GoenkaInvestor at Moonfire VenturesJames KuklinskiInvestor at Spark CapitalKerry KilleenAssociate General Counsel at Revolution

+ 600 more

Also attended Boston University192

Aydin SenkutFounder & Managing Partner at FelicisVinnie LauriaFounding Partner at Golden Gate VenturesGil GorenPartner at 83NorthJames LindenbaumCo-founder at HeavybitDave BiscegliaVenture Partner at Founder CollectiveKatherine OgnibeneOperations Associate at Founder Collective

+ 186 more

Shared employers

Also worked at Mission BioCapital8

Zach CollinsPartner at Mission BiocapitalDouglas CrawfordManaging General Partner at Mission BiocapitalJohannes FruehaufGeneral Partner at Mission BiocapitalPeter ParkerManaging General Partner at Mission BiocapitalChaya PatelPrincipal at Mission BiocapitalSteve TregayManaging General Partner at Mission Biocapital

+ 2 more

Also worked at University of Pennsylvania71

Wesley BarrowPartner at Correlation VenturesDavid MagermanManaging Partner at Differential VenturesNuan ZhangInvestor at Episode1Vyas RamananVenture Partner at Third Rock VenturesLouis BernemanFounding Partner at Osage University PartnersBrian HalakManaging Partner at Medical Excellence Capital

+ 65 more

Also worked at Flagship Pioneering66

Anika GuptaInvestor at GV (Google Ventures)Noubar AfeyanInvestor at Flagship PioneeringPatrickBiotech Investment Lead at Hummingbird VenturesSamir KaulInvestor at Khosla VenturesDiana BernsteinDirector at Northpond VenturesAnnie VemuSenior Associate at Longwood Fund

+ 60 more

Investments

Board seats

Mediar Therapeutics, Inc.Progentos Therapeutics, Inc.

Per SEC Form D filings.

Colleagues at Mission Biocapital

Chaya Patel
Principal at Mission Biocapital
Chris Carlin
Chief Operations Officer and Chief Compliance Officer at Mission Biocapital
Clay Rowland
Investment Associate at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Helen Siaw
Analyst at Mission Biocapital
Jennifer Griffin
Partner at Mission Biocapital
Johannes Fruehauf
General Partner at Mission Biocapital
Josephine Brysting
Investment Analyst at Mission Biocapital

Network5

Chaya Patel
Principal at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Helen Siaw
Analyst at Mission Biocapital
Jennifer Griffin
Partner at Mission Biocapital
Johannes Fruehauf
General Partner at Mission Biocapital

Investors connected to Cassidy in public investor directories — a warm-intro map.